4/A
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-21-001769
EVP R&D, Chief Medical Officer acquired 6,875 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-21 | Exercise or conversion : show line 1 in the form | +6,875 | 15,955 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-21 | Exercise or conversion : show line 2 in the form Restricted Stock Unit Award | −6,875 | 20,625 | D |
Loading xslF345X03/form4a.xml…